✦ LIBER ✦

Potential Role of Histone Deacetylase Inhibitors in Mesothelioma: Clinical Experience with Suberoylanilide Hydroxamic Acid

✍ Scribed by Lee M. Krug; Tracy Curley; Lawrence Schwartz; Stacie Richardson; Paul Marks; Judy Chiao; W. Kevin Kelly

Book ID: 119935537
Publisher: CIG Media Group, LP.
Year: 2006
Tongue: English
Weight: 564 KB
Volume: 7
Category: Article
ISSN: 1525-7304
DOI: 10.3816/clc.2006.n.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sequence-specific potentiation of topois

Sequence-specific potentiation of topoisomerase II inhibitors by the histone deacetylase inhibitor suberoylanilide hydroxamic acid

✍ Douglas C. Marchion; Elona Bicaku; Adil I. Daud; Victoria Richon; Daniel M. Sull 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 469 KB 👁 1 views

## Abstract Acetylation of histones leads to conformational changes of DNA. We have previously shown that the histone deacetylase (HDAC) inhibitor, suberoylanilide hydroxamic acid (SAHA), induced cell cycle arrest, differentiation, and apoptosis. In addition to their antitumor effects as single age

A phase I clinical trial of an oral form

A phase I clinical trial of an oral formulation of the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA)

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 139 KB

In vitro and in vivo histone deacetylase

In vitro and in vivo histone deacetylase inhibitor therapy with suberoylanilide hydroxamic acid (SAHA) and paclitaxel in ovarian cancer

✍ Amy L. Cooper; Victoria L. Greenberg; Pamela S. Lancaster; John R. van Nagell Jr 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 168 KB

Suberoylanilide hydroxamic acid, a histo

Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease

✍ Hockly, E.; Richon, V. M.; Woodman, B.; Smith, D. L.; Zhou, X.; Rosa, E.; Sathas 📂 Article 📅 2003 🏛 National Academy of Sciences 🌐 English ⚖ 476 KB

In vivo redox state of Human thioredoxin

In vivo redox state of Human thioredoxin and redox shift by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA)

✍ J. Ungerstedt; Y. Du; H. Zhang; D. Nair; A. Holmgren 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 622 KB

Phase 1 study of the histone deacetylase

Phase 1 study of the histone deacetylase inhibitor vorinostat (suberoylanilide hydroxamic acid [SAHA]) in patients with advanced leukemias and myelodysplastic syndromes

✍ Garcia-Manero, G.; Yang, H.; Bueso-Ramos, C.; Ferrajoli, A.; Cortes, J.; Wierda, 📂 Article 📅 2008 🏛 American Society of Hematology 🌐 English ⚖ 795 KB